128 related articles for article (PubMed ID: 12014918)
41. Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population.
Dherani M; Murthy GV; Gupta SK; Young IS; Maraini G; Camparini M; Price GM; John N; Chakravarthy U; Fletcher AE
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3328-35. PubMed ID: 18421094
[TBL] [Abstract][Full Text] [Related]
42. Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative.
Moeller SM; Voland R; Tinker L; Blodi BA; Klein ML; Gehrs KM; Johnson EJ; Snodderly DM; Wallace RB; Chappell RJ; Parekh N; Ritenbaugh C; Mares JA; ;
Arch Ophthalmol; 2008 Mar; 126(3):354-64. PubMed ID: 18332316
[TBL] [Abstract][Full Text] [Related]
43. Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes.
Bub A; Möseneder J; Wenzel G; Rechkemmer G; Briviba K
Eur J Nutr; 2008 Mar; 47(2):99-103. PubMed ID: 18320254
[TBL] [Abstract][Full Text] [Related]
44. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis.
Chong EW; Wong TY; Kreis AJ; Simpson JA; Guymer RH
BMJ; 2007 Oct; 335(7623):755. PubMed ID: 17923720
[TBL] [Abstract][Full Text] [Related]
45. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.
; SanGiovanni JP; Chew EY; Clemons TE; Ferris FL; Gensler G; Lindblad AS; Milton RC; Seddon JM; Sperduto RD
Arch Ophthalmol; 2007 Sep; 125(9):1225-32. PubMed ID: 17846363
[TBL] [Abstract][Full Text] [Related]
46. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Robman L; Vu H; Hodge A; Tikellis G; Dimitrov P; McCarty C; Guymer R
Can J Ophthalmol; 2007 Oct; 42(5):720-6. PubMed ID: 17724493
[TBL] [Abstract][Full Text] [Related]
47. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Parisi V; Tedeschi M; Gallinaro G; Varano M; Saviano S; Piermarocchi S;
Ophthalmology; 2008 Feb; 115(2):324-333.e2. PubMed ID: 17716735
[TBL] [Abstract][Full Text] [Related]
48. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
49. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD.
Cangemi FE
BMC Ophthalmol; 2007 Feb; 7():3. PubMed ID: 17324285
[TBL] [Abstract][Full Text] [Related]
50. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.
Schalch W; Cohn W; Barker FM; Köpcke W; Mellerio J; Bird AC; Robson AG; Fitzke FF; van Kuijk FJ
Arch Biochem Biophys; 2007 Feb; 458(2):128-35. PubMed ID: 17084803
[TBL] [Abstract][Full Text] [Related]
51. Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention.
Kopsell DA; Lefsrud MG; Kopsell DE; Wenzel AJ; Gerweck C; Curran-Celentano J
J Agric Food Chem; 2006 Oct; 54(21):7998-8005. PubMed ID: 17032001
[TBL] [Abstract][Full Text] [Related]
52. Use of onion extract, heparin, allantoin gel in prevention of scarring in chinese patients having laser removal of tattoos: a prospective randomized controlled trial.
Ho WS; Ying SY; Chan PC; Chan HH
Dermatol Surg; 2006 Jul; 32(7):891-6. PubMed ID: 16875470
[TBL] [Abstract][Full Text] [Related]
53. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].
Bahrami H; Melia M; Dagnelie G
BMC Ophthalmol; 2006 Jun; 6():23. PubMed ID: 16759390
[TBL] [Abstract][Full Text] [Related]
54. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
[TBL] [Abstract][Full Text] [Related]
55. Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans.
Chen L; Collins XH; Tabatabai LB; White WS
Lipids; 2005 Oct; 40(10):1013-22. PubMed ID: 16382573
[TBL] [Abstract][Full Text] [Related]
56. Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial.
Cheng CY; Chung WY; Szeto YT; Benzie IF
Br J Nutr; 2005 Jan; 93(1):123-30. PubMed ID: 15705234
[TBL] [Abstract][Full Text] [Related]
57. Lutein and beta-carotene from lutein-containing yellow carrots are bioavailable in humans.
Molldrem KL; Li J; Simon PW; Tanumihardjo SA
Am J Clin Nutr; 2004 Jul; 80(1):131-6. PubMed ID: 15213039
[TBL] [Abstract][Full Text] [Related]
58. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).
Richer S; Stiles W; Statkute L; Pulido J; Frankowski J; Rudy D; Pei K; Tsipursky M; Nyland J
Optometry; 2004 Apr; 75(4):216-30. PubMed ID: 15117055
[TBL] [Abstract][Full Text] [Related]
59. Decreased carotenoid concentrations due to dietary sucrose polyesters do not affect possible markers of disease risk in humans.
Broekmans WM; Klöpping-Ketelaars IA; Weststrate JA; Tijburg LB; van Poppel G; Vink AA; Berendschot TT; Bots ML; Castenmiller WA; Kardinaal AF
J Nutr; 2003 Mar; 133(3):720-6. PubMed ID: 12612143
[TBL] [Abstract][Full Text] [Related]
60. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment.
Falsini B; Piccardi M; Iarossi G; Fadda A; Merendino E; Valentini P
Ophthalmology; 2003 Jan; 110(1):51-60; discussion 61. PubMed ID: 12511345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
